RIP3, a novel apoptosis-inducing kinase. |
| |
Authors: | X Sun J Lee T Navas D T Baldwin T A Stewart V M Dixit |
| |
Institution: | Departments of Molecular Oncology, Genentech, Inc., South San Francisco, California 94080, USA. |
| |
Abstract: | RIP3 is a novel gene product containing a N-terminal kinase domain that shares extensive homology with the corresponding domain in RIP (receptor-interacting protein) and RIP2. Unlike RIP, which has a C-terminal death domain, and RIP2, which has a C-terminal caspase activation and recruitment domain, RIP3 has a unique C terminus. RIP3 binds RIP through its unique C-terminal segment and by virtue of this interaction is recruited to the tumor necrosis factor (TNF) receptor-1 signaling complex. Previous studies have shown that RIP mediates TNF-induced activation of the anti-apoptotic NF-kappaB pathway. RIP3, however, attenuates both RIP and TNF receptor-1-induced NF-kappaB activation. Overexpression studies revealed RIP3 to be a potent inducer of apoptosis, capable of selectively binding to large prodomain initiator caspases. |
| |
Keywords: | |
|
|